Found: 22
Select item for more details and to access through your institution.
Adoptive immunotherapy for cancer: building on success.
- Published in:
- 2006
- By:
- Publication type:
- journal article
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Folate Receptor Beta as a Direct and Indirect Target for Antibody-Based Cancer Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5572, doi. 10.3390/ijms22115572
- By:
- Publication type:
- Article
A Novel Approach for the Treatment of T Cell Malignancies: Targeting T Cell Receptor Vβ Families.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 631, doi. 10.3390/vaccines8040631
- By:
- Publication type:
- Article
Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049829
- By:
- Publication type:
- Article
Day-4 Myeloid Dendritic Cells Pulsed with Whole Tumor Lysate Are Highly Immunogenic and Elicit Potent Anti-Tumor Responses.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028732
- By:
- Publication type:
- Article
Mannose Receptor (MR) Engagement by Mesothelin GPI Anchor Polarizes Tumor-Associated Macrophages and Is Blocked by Anti-MR Human Recombinant Antibody.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028386
- By:
- Publication type:
- Article
Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3<sup>p53-/-</sup> mice.
- Published in:
- Oncogene, 2001, v. 20, n. 25, p. 3235, doi. 10.1038/sj.onc.1204425
- By:
- Publication type:
- Article
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor in?ltrating lymphocytes.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1256491
- By:
- Publication type:
- Article
A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitope.
- Published in:
- Mobile DNA, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13100-024-00333-w
- By:
- Publication type:
- Article
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022).
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04117-3
- By:
- Publication type:
- Article
P-007: Exploring a safety switch in NKG2D and BCMA CAR NK-92MI immunotherapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S42, doi. 10.1016/S2152-2650(21)02141-8
- By:
- Publication type:
- Article
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 8, p. 1, doi. 10.1038/s41408-021-00537-w
- By:
- Publication type:
- Article
CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 134, p. 1, doi. 10.1126/scitranslmed.3003330
- By:
- Publication type:
- Article
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 414, doi. 10.1186/s12967-014-0347-2
- By:
- Publication type:
- Article
IL-21 promotes the expansion of CD27<sup>+</sup> CD28<sup>+</sup> tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-37
- By:
- Publication type:
- Article
A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 157, doi. 10.1186/1479-5876-10-157
- By:
- Publication type:
- Article
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Effective adoptive immunotherapy of triplenegative breast cancer by folate receptoralpha redirected CAR T cells is influenced by surface antigen expression level.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0285-y
- By:
- Publication type:
- Article
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response.
- Published in:
- Molecules, 2020, v. 25, n. 24, p. 6029, doi. 10.3390/molecules25246029
- By:
- Publication type:
- Article
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04209-8
- By:
- Publication type:
- Article